A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality

por Akgun, Zuleyha, Cakir, Aydin, Sağlam, Esra, Demirel, Sertac, Igci, Abdullah, Keskin, Serkan
Publicado 2023

Is the thymidine labeling index a good prognostic marker in breast cancer?

por Sen-Oran, Ebru, Ozmen, Vahit, Bilir, Ayhan, Cabioglu, Neslihan, Muslumanoglu, Mahmut, Igci, Abdullah, Guney, Nese, Kecer, Mustafa
Publicado 2007

Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy

por GEZER, UGUR, KESKIN, SERKAN, İĞCI, ABDULLAH, TÜKENMEZ, MUSTAFA, TIRYAKIOĞLU, DUYGU, ÇETINKAYA, MERVE, DIŞCI, RIAN, DALAY, NEJAT, ERALP, YEŞIM
Publicado 2014

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?

por Emiroglu, Selman, Özkurt, Enver, Cabıoglu, Neslihan, Igci, Abdullah, Saip, Pinar, Yazici, Hulya, Ozmen, Tolga, Ozmen, Vahit, Muslumanoglu, Mahmut, Tukenmez, Mustafa
Publicado 2023

Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up

por Özkurt, Enver, Tükenmez, Mustafa, Güven, Erdem, Çelet Özden, Burcu, Öner, Gizem, Müslümanoğlu, Mahmut, İğci, Abdullah, Özmen, Vahit, Küçücük, Seden, Cabioğlu, Neslihan
Publicado 2018

Breast cancer risk factors in Turkish women – a University Hospital based nested case control study

por Ozmen, Vahit, Ozcinar, Beyza, Karanlik, Hasan, Cabioglu, Neslihan, Tukenmez, Mustafa, Disci, Rian, Ozmen, Tolga, Igci, Abdullah, Muslumanoglu, Mahmut, Kecer, Mustafa, Soran, Atilla
Publicado 2009

High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer

por Mollavelioglu, Baran, Cetin Aktas, Esin, Cabioglu, Neslihan, Abbasov, Aykhan, Onder, Semen, Emiroglu, Selman, Tükenmez, Mustafa, Muslumanoglu, Mahmut, Igci, Abdullah, Deniz, Gunnur, Ozmen, Vahit
Publicado 2022

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

por Cabioglu, Neslihan, Onder, Semen, Oner, Gizem, Karatay, Hüseyin, Tukenmez, Mustafa, Muslumanoglu, Mahmut, İgci, Abdullah, Eralp, Yeşim, Aydiner, Adnan, Saip, Pınar, Yavuz, Ekrem, Ozmen, Vahit
Publicado 2021

Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

por Oner, Gizem, Önder, Semen, Karatay, Hüseyin, Ak, Naziye, Tükenmez, Mustafa, Müslümanoğlu, Mahmut, İğci, Abdullah, Dincçağ, Ahmet, Özmen, Vahit, Aydiner, Adnan, Yavuz, Ekrem, Cabioğlu, Neslihan
Publicado 2021

Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

por Oner, Gizem, Önder, Semen, Karatay, Hüseyin, Ak, Naziye, Tükenmez, Mustafa, Müslümanoğlu, Mahmut, İğci, Abdullah, Dincçağ, Ahmet, Özmen, Vahit, Aydiner, Adnan, Yavuz, Ekrem, Cabioğlu, Neslihan
Publicado 2023

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

por Cabioglu, Neslihan, Bayram, Aysel, Emiroglu, Selman, Onder, Semen, Karatay, Huseyin, Oner, Gizem, Tukenmez, Mustafa, Muslumanoglu, Mahmut, Igci, Abdullah, Aydiner, Adnan, Saip, Pinar, Yavuz, Ekrem, Ozmen, Vahit
Publicado 2023

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment

por Aydiner, Adnan, Sen, Fatma, Tambas, Makbule, Ciftci, Rumeysa, Eralp, Yesim, Saip, Pinar, Karanlik, Hasan, Fayda, Merdan, Kucucuk, Seden, Onder, Semen, Yavuz, Ekrem, Muslumanoglu, Mahmut, Igci, Abdullah
Publicado 2015

Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis

por Cabioglu, Neslihan, Trabulus, Didem Can, Emiroglu, Selman, Ozkurt, Enver, Yalcin, Nesli, Dinc, Nagehan, Tukenmez, Mustafa, Muslumanoglu, Mahmut, Igci, Abdullah, Ozmen, Vahit, Dinccag, Ahmet Sait, Guven, Yusuf Izzettin
Publicado 2023